Diagnosis of Zollinger–Ellison Syndrome in the Era of Ppis, Faulty Gastrin Assays, Sensitive Imaging and Limited Access to Acid Secretory Testing

References

• Ito T , IgarashiH, JensenRT. Pancreatic neuroendocrine tumors: clinical features, diagnosis and medical treatment: advances. Best Pract. Res. Clin. Gastroenterol.26, 737–753 (2012).
   PubMed Web of Science ®Google Scholar
• Roy PK , VenzonDJ, ShojamaneshHet al. Zollinger–Ellison syndrome: clinical presentation in 261 patients. Medicine (Baltimore)79(6), 379–411 (2000).
   PubMed Web of Science ®Google Scholar
• Metz DC , JensenRT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology135, 1469–1492 (2008).
   PubMed Web of Science ®Google Scholar
• Ito T , IgarashiH, JensenRT. Zollinger–Ellison syndrome: recent advances and controversies. Curr. Opin. Gastroenterol.29, 650–661 (2013).
   PubMed Web of Science ®Google Scholar
• Thom AK , NortonJA, AxiotisCA, JensenRT. Location, incidence and malignant potential of duodenal gastrinomas. Surgery110, 1086–1093 (1991).
   PubMed Web of Science ®Google Scholar
• Pipeleers-Marichal M , SomersG, WillemsGet al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger–Ellison syndrome. N. Engl. J. Med.322, 723–727 (1990).
   PubMed Web of Science ®Google Scholar
• Gibril F , SchumannM, PaceA, JensenRT. Multiple endocrine neoplasia type 1 and Zollinger–Ellison syndrome. A prospective study of 107 cases and comparison with 1009 patients from the literature. Medicine (Baltimore)83(1), 43–83 (2004).
   PubMed Web of Science ®Google Scholar
• Jensen RT , BernaMJ, BinghamMD, NortonJA. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management and controversies. Cancer113(7 Suppl.), 1807–1843 (2008).
   PubMed Web of Science ®Google Scholar
• Jensen RT . Zollinger–Ellison syndrome. In: Yamada’s Textbook of Gastroenterology. PodolskyDK, CamilleriM, FitzJGKAN, ShanahanF, WangTC ( Eds). John Wiley and Sons, Ltd. West Sussex, UK, 1078–1102 (2015).
   Google Scholar
• Roy PK , VenzonDJ, FeigenbaumKMet al. Gastric secretion in Zollinger–Ellison syndrome: correlation with clinical expression, tumor extent and role in diagnosis - A prospective NIH study of 235 patients and review of the literature in 984 cases. Medicine(Baltimore)80(3), 189–222 (2001).
   PubMed Web of Science ®Google Scholar
• Ito T , IgarashiH, UeharaH, JensenRT. Pharmacotherapy of Zollinger–Ellison syndrome. Expert Opin. Pharmacother.14(3), 307–321 (2013).
   PubMed Web of Science ®Google Scholar
• Jensen RT , NiederleB, MitryEet al. Gastrinoma (duodenal and pancreatic). Neuroendocrinology84(3), 173–182 (2006).
   PubMed Web of Science ®Google Scholar
• Osefo N , ItoT, JensenRT. Gastric acid hypersecretory states: recent insights and advances. Curr. Gastroenterol. Rep.11(6), 433–441 (2009).
   PubMedGoogle Scholar
• Jensen RT , NortonJA, ObergK. Neuroendocrine tumors. In: Sleisenger and Fordtran’s Gastrointestinal and Liver Diseases. FeldmanM, FriedmanLS, BrandtLJ ( Eds). Elsevier Saunders, Philadelphia, PA, 501–541 (2016.).
   Google Scholar
• Falconi M , ErikssonB, KaltsasGet al. ENETS Consensus Guidelines Update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine tumors. Neuroendocrinology103(2), 153–171 (2016).
   PubMed Web of Science ®Google Scholar
• Anlauf M , GarbrechtN, HenoppTet al. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World J.12(34), 5440–5446 (2006).
   Google Scholar
• Jensen RT , GardnerJD. Gastrinoma. In: The Pancreas: Biology, Pathobiology and Disease. GoVLW, DiMagnoEP, GardnerJDet al. ( Eds). Raven Press Publishing Co., New York, 931–978 (1993).
   Google Scholar
• Ito T , IgarashiH, UeharaH, BernaMJ, JensenRT. Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors. Medicine (Baltimore)92(3), 135–181 (2013).
   PubMed Web of Science ®Google Scholar
• Mignon M , CadiotG. Natural history of gastrinoma: lessons from the past. Ital. J. Gastroenterol. Hepatol.31(Suppl. 2), S98–S103 (1999).
   PubMedGoogle Scholar
• Ellison EH , WilsonSD. The Zollinger-Ellison syndrome: re-appraisal and evaluation of 260 registered cases. Ann. Surg.160, 512–530 (1964).
   PubMed Web of Science ®Google Scholar
• Zollinger RM , EllisonEH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann. Surg.142, 709–728 (1955).
   PubMed Web of Science ®Google Scholar
• Collen MJ , HowardJM, McArthurKEet al. Comparison of ranitidine and cimetidine in the treatment of gastric hypersecretion. Ann. Intern. Med.100, 52–58 (1984).
   PubMed Web of Science ®Google Scholar
• Metz DC , PisegnaJR, FishbeynVA, BenyaRV, JensenRT. Control of gastric acid hypersecretion in the management of patients with Zollinger-Ellison syndrome. World J. Surg.17, 468–480 (1993).
   PubMed Web of Science ®Google Scholar
• Nieto JM , PisegnaJR. The role of proton pump inhibitors in the treatment of Zollinger-Ellison syndrome. Expert Opin. Pharmacother.7(2), 169–175 (2006).
   PubMed Web of Science ®Google Scholar
• Phan J , BenhammouJN, PisegnaJR. Gastric hypersecretory states: investigation and management. Curr. Treat. Options Gastroenterol.13(4), 386–397 (2015).
   PubMedGoogle Scholar
• Metz DC , SostekMB, RuszniewskiPet al. Effects of esomeprazole on acid output in patients with zollinger-ellison syndrome or idiopathic gastric acid hypersecretion. Am. J. Gastroenterol.102(12), 2648–2654 (2007).
   PubMed Web of Science ®Google Scholar
• Hirschowitz BI , SimmonsJ, MohnenJ. Clinical outcome using lansoprazole in acid hypersecretors with and without Zollinger-Ellison syndrome: a 13 year prospective study. Clin. Gastroenterol. Hepatol.3(1), 39–48 (2005).
   PubMed Web of Science ®Google Scholar
• Metz DC , StraderDB, OrbuchMet al. Use of omeprazole in Zollinger-Ellison: a prospective nine-year study of efficacy and safety. Aliment. Pharmacol. Ther.7, 597–610 (1993).
   PubMed Web of Science ®Google Scholar
• Norton JA , FrakerDL, AlexanderHRet al. Surgery to cure the Zollinger-Ellison syndrome. N. Engl. J. Med.341(9), 635–644 (1999).
   PubMed Web of Science ®Google Scholar
• Norton JA , FrakerDL, AlexanderHR, JensenRT. Value of surgery in patients with negative imaging and sporadic Zollinger-Ellison syndrome. Ann. Surg.256(3), 509–517 (2012).
   PubMed Web of Science ®Google Scholar
• Atema JJ , AmriR, BuschORet al. Surgical treatment of gastrinomas: a single-centre experience. HPB (Oxford)14(12), 833–838 (2012).
   PubMed Web of Science ®Google Scholar
• Norton JA , AlexanderHR, FrakerDLet al. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann. Surg.234(4), 495–506 (2001).
   PubMed Web of Science ®Google Scholar
• Ito T , JensenRT. Imaging in multiple endocrine neoplasia type 1: recent studies show enhanced sensitivities but increased controversies. Int. J. Endocr. Oncol.3(1), 53–66 (2016).
   PubMed Web of Science ®Google Scholar
• Norton JA , KrampitzG, JensenRT. Multiple endocrine neoplasia: genetics and clinical management. Surg. Oncol. Clin. N. Am.24(4), 795–832 (2015).
   PubMed Web of Science ®Google Scholar
• Bartsch DK , AlbersMB. Controversies in surgery for multiple endocrine neoplasia type-1- associated Zollinger-Ellison syndrome. Int. J. Endo. Oncol.2(4), 263–271 (2015).
   Google Scholar
• Kulke MH , AnthonyLB, BushnellDLet al. NANETS Treatment Guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas39(6), 735–752 (2010).
   PubMed Web of Science ®Google Scholar
• Norton JA , FrakerDL, AlexanderHRet al. Surgery increases survival in patients with gastrinoma. Ann. Surg.244(3), 410–419 (2006).
   PubMed Web of Science ®Google Scholar
• Singh MH , FrakerDL, MetzDC. Importance of surveillance for multiple endocrine neoplasia-1 and surgery in patients with sporadic Zollinger-Ellison syndrome. Clin. Gastroenterol. Hepatol.10(11), 1262–1269 (2012).
   PubMed Web of Science ®Google Scholar
• Fraker DL , NortonJA, AlexanderHR, VenzonDJ, JensenRT. Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann. Surg.220, 320–330 (1994).
   PubMed Web of Science ®Google Scholar
• Yu F , VenzonDJ, SerranoJet al. Prospective study of the clinical course, prognostic factors and survival in patients with longstanding Zollinger-Ellison syndrome. J. Clin. Oncol.17, 615–630 (1999).
   PubMed Web of Science ®Google Scholar
• Ito T , IgarashiH, JensenRT. Therapy of metastatic pancreatic neuroendocrine tumors (pNETs): recent insights and advances. J. Gastroenterol.47(9), 941–960 (2012).
   PubMed Web of Science ®Google Scholar
• Berna MJ , HoffmannKM, SerranoJ, GibrilF, JensenRT. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine (Baltimore)85, 295–330 (2006).
   PubMed Web of Science ®Google Scholar
• Grimaldi F , FazioN, AttanasioRet al. Italian Association of Clinical Endocrinologists (AME) position statement: a stepwise clinical approach to the diagnosis of gastroenteropancreatic neuroendocrine neoplasms. J. Endocrinol. Invest.37(9), 875–909 (2014).
   PubMed Web of Science ®Google Scholar
• Jensen RT , CadiotG, BrandiMLet al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology95(2), 98–119 (2012).
   PubMed Web of Science ®Google Scholar
• Metz DC . Diagnosis of the Zollinger-Ellison syndrome. Clin. Gastroenterol. Hepatol.10(2), 126–130 (2012).
   PubMed Web of Science ®Google Scholar
• Murugesan SV , VarroA, PritchardDM. Review article: strategies to determine whether hypergastrinaemia is due to Zollinger–Ellison syndrome rather than a more common benign cause. Aliment. Pharmacol. Ther.29(10), 1055–1068 (2009).
   PubMed Web of Science ®Google Scholar
• Cadiot G , JaisP, MignonM. Diagnosis of Zollinger-Ellison syndrome. From symptoms to biological evidence. Ital. J. Gastroenterol. Hepatol.31, S147–S152 (1999).
   PubMedGoogle Scholar
• Banasch M , SchmitzF. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors. Wien. Klin. Wochenschr.119(19–20), 573–578 (2007).
   PubMed Web of Science ®Google Scholar
• Yanda RJ , OstroffJW, AshbaughCD, GuisMS, GoldbergHI. Zollinger-Ellison syndrome in a patient with normal screening gastrin level. Dig. Dis. Sci.34, 1929–1932 (1989).
   PubMed Web of Science ®Google Scholar
• Jais P , MignonM. Normal serum gastrin concentration in gastrinoma [letter]. Lancet346, 1421–1422 (1995).
   PubMed Web of Science ®Google Scholar
• Fishbeyn VA , NortonJA, BenyaRVet al. Assessment and prediction of long-term cure in patients with Zollinger-Ellison syndrome: the best approach. Ann. Intern. Med.119, 199–206 (1993).
   PubMed Web of Science ®Google Scholar
• Norton JA , VenzonDJ, BernaMJet al. Prospective study of surgery for primary hyperaparathyroidism (HPT) in Multiple Endocrine Neoplasia type 1 (MEN1), and Zollinger-Ellison syndrome (ZES): long-term outcome of a more virulent form of HPT. Ann. Surgery247(3), 501–510 (2008).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , BardramL, HilstedL, PoitrasP, GoetzeJP. Pitfalls in diagnostic gastrin measurements. Clin. Chem.58(5), 831–836 (2012).
   PubMed Web of Science ®Google Scholar
• Rehfeld JF , GingrasMH, BardramLet al. The Zollinger-Ellison syndrome and mismeasurement of gastrin. Gastroenterology140(5), 1444–1453 (2011).
   PubMed Web of Science ®Google Scholar
• Schubert ML , PeuraDA. Control of gastric acid secretion in health and disease. Gastroenterology134(7), 1842–1860 (2008).
   PubMed Web of Science ®Google Scholar
• Papay KD , FalckVG, PoulsenSSet al. Juvenile polyposis of the stomach – a novel cause of hypergastrinemia. Nat. Rev. Gastroenterol. Hepatol.7(10), 583–588 (2010).
   PubMed Web of Science ®Google Scholar
• Metz DC , WeberHC, OrbuchMet al. Helicobacter pylori infection: a reversible cause of hypergastrinemia and hyperchlorhydria which can mimic Zollinger-Ellison syndrome. Dig. Dis. Sci.40, 153–159 (1995).
   PubMed Web of Science ®Google Scholar
• Annibale B , RindiG, D’AmbraGet al. Antral gastrin cell hyperfunction and helicobacter pylori infection. Aliment. Pharmacol. Ther.10, 607–615 (1996).
   PubMed Web of Science ®Google Scholar
• Gibril F , ReynoldsJC, DoppmanJLet al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study. Ann. Intern. Med.125, 26–34 (1996).
   PubMed Web of Science ®Google Scholar
• Ito T , CadiotG, JensenRT. Diagnosis of Zollinger-Ellison syndrome: Increasingly difficult. World J. Gastroenterol.18(39), 5495–5503 (2012).
   PubMed Web of Science ®Google Scholar
• Borch K , RenvallH, LiedbergG, AndersenBN. Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand. J. Gastroenterol.21, 357–363 (1986).
   PubMed Web of Science ®Google Scholar
• Vannella L , Sbrozzi-VanniA, LahnerEet al. Development of type I gastric carcinoid in patients with chronic atrophic gastritis. Aliment. Pharmacol. Ther.33(12), 1361–1369 (2011).
   PubMed Web of Science ®Google Scholar
• Delle Fave G , MarignaniM, MorettiAet al. Hypergastrinemia and enterochromaffin-like cell hyperplasia. Yale J. Biol. Med.71, 291–301 (1998).
   PubMed Web of Science ®Google Scholar
• Borch K , StridsbergM, BurmanP, RehfeldJF. Basal chromogranin A and gastrin concentrations in circulation correlate to endocrine cell proliferation in type-A gastritis. Scand. J. Gastroenterol.32(3), 198–202 (1997).
   PubMed Web of Science ®Google Scholar
• Raines D , ChesterM, DieboldAEet al. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans. Pancreas41(4), 508–511 (2012).
   PubMed Web of Science ®Google Scholar
• Sanduleanu S , DeBruineA, StridsbergMet al. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. Eur. J. Clin. Invest.31(9), 802–811 (2001).
   PubMed Web of Science ®Google Scholar
• Dhillo WS , JayasenaCN, LewisCJet al. Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists. Ann. Clin. Biochem.43(Pt 2), 153–155 (2006).
   PubMedGoogle Scholar
• Lamberts R , CreutzfeldtW, StockmannFet al. Long term omeprazole treatment in man: effects on gastric endocrine cell populations. Digestion39, 126–135 (1988).
   PubMed Web of Science ®Google Scholar
• Pregun I , HerszenyiL, JuhaszMet al. Effect of proton-pump inhibitor therapy on serum chromogranin a level. Digestion84(1), 22–28 (2011).
   PubMed Web of Science ®Google Scholar
• Jansen JB , Klinkenberg-KnolEC, MeuwissenSGet al. Effect of long-term treatment with omeprazole on serum gastrin and serum group A and C pepsinogens in patients with reflux esophagitis. Gastroenterology99, 621–628 (1990).
   PubMed Web of Science ®Google Scholar
• Metz DC , ForsmarkC, LewEAet al. Replacement of oral proton pump inhibitors with intravenous pantoprazole to effectively control gastric acid hypersecretion in patients with Zollinger-Ellison syndrome. Am. J. Gastroenterol.96(12), 3274–3280 (2001).
   PubMed Web of Science ®Google Scholar
• Oberg K , CouvelardA, Delle FaveGet al. ENETS Consensus Guidelines for standard of care in neuroendocrine tumours: biochemical markers. Neuroendocrinology (2017).
   Google Scholar
• Benya RV , MetzDC, VenzonDJet al. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am. J. Med.97, 436–444 (1994).
   PubMed Web of Science ®Google Scholar
• Lopez CL , FalconiM, WaldmannJet al. Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1. Ann. Surg.257(2), 308–314 (2013).
   PubMed Web of Science ®Google Scholar
• Jensen RT , NortonJA. Treatment of pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: some clarity but continued controversy. Pancreas46(5), 589–594 (2017).
   PubMed Web of Science ®Google Scholar
• Singh Ospina N , DoneganD, Rodriguez-GutierrezR, Al-HilliZ, YoungWFJr. Assessing for multiple endocrine neoplasia type 1 in patients evaluated for Zollinger-Ellison Syndrome – clues to a safer diagnostic process. Am. J. Med.130(5), 603–605 (2017).
   PubMed Web of Science ®Google Scholar
• Berna MJ , HoffmannKM, LongSHet al. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features. Medicine (Baltimore)85(6), 331–364 (2006).
   PubMed Web of Science ®Google Scholar
• Poitras P , GingrasMH, RehfeldJF. Secretin stimulation test for gastrin release in zollinger-ellison syndrome: to do or not to do?Pancreas42(6), 903–904 (2013).
   PubMed Web of Science ®Google Scholar
• Shah P , SinghMH, YangYX, MetzDC. Hypochlorhydria and achlorhydria are associated with false-positive secretin stimulation testing for zollinger-ellison syndrome. Pancreas42(6), 932–936 (2013).
   PubMed Web of Science ®Google Scholar
• Metz DC , BuchananM, PurichE, FeinS. A randomized controlled crossover study comparing synthetic porcine and human secretins with biologically derived porcine secretin to diagnose Zollinger-Ellison Syndrome. Aliment. Pharmacol. Ther.15(5), 669–676 (2001).
   PubMed Web of Science ®Google Scholar
• Matsubayashi H , KawataN, KakushimaNet al. A case of type 1 multiple endocrine neoplasia with esophageal stricture successfully treated with endoscopic balloon dilation and local steroid injection combined with surgical resection of gastrinomas. BMC Gastroenterol.17(1), 37 (2017).
   PubMedGoogle Scholar
• Lenhart A , HassanM, MeighaniA, SadiqO, SiddiquiY. A perplexing case of abdominal pain that led to the diagnosis of Zollinger-Ellison Syndrome. Case Rep. Gastrointest. Med. 2017, 7636952 (2017).
   Google Scholar
• Aamar A , MadhaniK, VirkH, ButtZ. Zollinger-Ellison syndrome: a rare case of chronic diarrhea. Gastroenterol. Res.9(6), 103–104 (2016).
   PubMedGoogle Scholar
• Lee HW , ChungJW, KimYJet al. Synchronous peripancreatic lymph node gastrinoma and gastric neuroendocrine tumor type 2. Clin. Endosc.49(5), 483–487 (2016).
   PubMedGoogle Scholar
• Twerdahl EH , CostantinoCL, FerroneCR, HodinRA. Primary hepatic gastrinoma. J. Gastrointest. Surg.20(3), 662–663 (2016).
   PubMed Web of Science ®Google Scholar
• Goyal R , DebiU, DeyP, PrasadKK, ThapaBR. Zollinger-Ellison syndrome: an unusual case of chronic diarrhoea in a child. Malays. J. Pathol.38(3), 321–325 (2016).
   PubMed Web of Science ®Google Scholar
• Sparkman BK , EarlTM. Sporadic, primary lymph node gastrinoma. Am. Surg.82(7), 155–157 (2016).
   Web of Science ®Google Scholar
• Alshikho MJ , NoureldineSI, TalasJMet al. Zollinger-Ellison syndrome associated with von Recklinghausen disease: case report and literature review. Am. J. Case Rep.17, 398–405 (2016).
   PubMedGoogle Scholar
• Zhang WD , LiuDR, WangPet al. Clinical treatment of gastrinoma: A case report and review of the literature. Oncol. Lett.11(5), 3433–3437 (2016).
   PubMed Web of Science ®Google Scholar
• Ogawa S , WadaM, FukushimaMet al. Case of primary hepatic gastrinoma: Diagnostic usefulness of the selective arterial calcium injection test. Hepatol. Res.45(7), 823–826 (2015).
   PubMed Web of Science ®Google Scholar
• Harper S , CarrollRW, FrillingA, WickremesekeraSK, BannS. Primary lymph node gastrinoma: 2 cases and a review of the literature. J. Gastrointest. Surg.19(4), 651–655 (2015).
   PubMed Web of Science ®Google Scholar
• Teng A , HaasC, LeeDYet al. Primary lymph node gastrinoma. A diagnosis of exclusion. A case for duodenotomy in the setting of a negative imaging for primary tumor: A case report and review of the literature. Int. J. Surg. Case Rep.5(11), 849–852 (2014).
   PubMedGoogle Scholar
• Stroker E , LeoneL, VandeputY, BorbathI, LefebvreC. Severe symptomatic hypomagnesaemia induced by the chronic use of proton pump inhibitors: a case report of a patient with Zollinger-Ellison syndrome. Acta Clin. Belg.69(1), 62–65 (2014).
   PubMed Web of Science ®Google Scholar
• Lee NE , LeeYJ, YunSHet al. A case of Zollinger-Ellison syndrome in multiple endocrine neoplasia type 1 with urolithiasis as the initial presentation. Korean J. Gastroenterol.61(6), 333–337 (2013).
   PubMedGoogle Scholar
• Okada K , SudoT, MiyamotoKet al. The selective arterial calcium injection test is a valid diagnostic method for invisible gastrinoma with duodenal ulcer stenosis: A case report. Hiroshima J. Med. Sci.65(1), 13–17 (2016).
   PubMedGoogle Scholar
• Atalar K , WarrenOJ, JacynaM, JiaoLR. Laparoscopic resection for primary lymph node gastrinoma. Pancreas42(4), 723–725 (2013).
   PubMed Web of Science ®Google Scholar
• Campana D , FusaroliP, CacciariG. Multiple gastrinomas of the duodenum in a patient with sporadic Zollinger-Ellison syndrome. Endocrine44(3), 815–816 (2013).
   PubMed Web of Science ®Google Scholar
• Citak EC , TaskinlarH, ArpaciRBet al. Primary lymph node gastrinoma: a rare cause of abdominal pain in childhood. J. Pediatr. Hematol. Oncol.35(5), 394–398 (2013).
   PubMed Web of Science ®Google Scholar
• Jayaram P , ShindelA, BuxbaumJ. Duodenal gastrinoma discovered on evaluation for incidental gastric carcinoid. Clin. Gastroenterol. Hepatol.15(10), e154–e155 (2017).
   PubMed Web of Science ®Google Scholar
• Murase N , UchidaH, TainakaTet al. Laparoscopic-assisted pancreaticoduodenectomy in a child with gastrinoma. Pediatr. Int.57(6), 1196–1198 (2015).
   PubMed Web of Science ®Google Scholar
• Pinto-Sanchez MI , YuanY, BercikP, MoayyediP. Proton pump inhibitors for functional dyspepsia. Cochrane Database Syst. Rev.3, CD011194 (2017).
   Google Scholar
• Ahrens D , BehrensG, HimmelW, KochenMM, ChenotJF. Appropriateness of proton pump inhibitor recommendations at hospital discharge and continuation in primary care. Int. J. Clin. Pract.66(8), 767–773 (2012).
   PubMed Web of Science ®Google Scholar
• Corleto VD , AnnibaleB, GibrilFet al. Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome? Aliment. Pharmacol. Ther. 15, 1555–1561 (2001).
   PubMed Web of Science ®Google Scholar
• Arnold R . Diagnosis and differential diagnosis of hypergastrinemia. Wien. Klin. Wochenschr.119(19–20), 564–569 (2007).
   PubMed Web of Science ®Google Scholar
• Lundell L , ViethM, GibsonF, NagyP, KahrilasPJ. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment. Pharmacol. Ther.42(6), 649–663 (2015).
   PubMed Web of Science ®Google Scholar
• Poitras P , GingrasMH, RehfeldJF. The Zollinger-Ellison syndrome: dangers and consequences of interrupting antisecretory treatment. Clin. Gastroenterol. Hepatol.10(2), 199–202 (2012).
   PubMed Web of Science ®Google Scholar
• Gibril F , ReynoldsJC, ChenCCet al. Specificity of somatostatin receptor scintigraphy: a prospective study and the effects of false positive localizations on management in patients with gastrinomas. J. Nucl. Med.40, 539–553 (1999).
   PubMed Web of Science ®Google Scholar
• Ito T , JensenRT. Molecular imaging in neuroendocrine tumors: recent advances, controversies, unresolved issues, and roles in management. Curr. Opin. Endocrinol. Diabetes Obes.24(1), 15–24 (2017).
   PubMedGoogle Scholar
• Fendler WP , BarrioM, SpickCet al. 68Ga-DOTATATE PET/CT interobserver agreement for neuroendocrine tumor assessments: results from a prospective study on 50 patients. J. Nucl. Med.58(2), 307–311 (2016).
   PubMed Web of Science ®Google Scholar
• Matsumura S , OkuyamaY, DoiRet al. (68)Ga-DOTATOC-PET/CT for effective diagnosis and treatment of pancreatic tail gastrinoma with multiple liver metastases: a case report. Nihon Shokakibyo Gakkai Zasshi113(1), 86–93 (2016).
   PubMedGoogle Scholar
• Kjaer A , KniggeU. Use of radioactive substances in diagnosis and treatment of neuroendocrine tumors. Scand. J. Gastroenterol.50(6), 740–747 (2015).
   PubMed Web of Science ®Google Scholar
• Ambrosini V , FantiS. 68Ga-DOTA-peptides in the diagnosis of NET. PET Clin.9(1), 37–42 (2014).
   PubMedGoogle Scholar
• Campana D , BrocchiE, TomassettiP. Multiple gastric endocrine tumours and gastrinomas of the duodenum in a patient with ZES MEN 1. Dig. Liver Dis.40(6), 476 (2008).
   PubMedGoogle Scholar
• McGuigan JE , WolfeMM. Secretin injection test in the diagnosis of gastrinoma. Gastroenterology79, 1324–1331 (1980).
   PubMed Web of Science ®Google Scholar
• Deveney CW , DeveneyKS, JaffeBM, JonesRS, WayLW. Use of calcium and secretin in the diagnosis of gastrinoma (Zollinger-Ellison syndrome). Ann. Intern. Med.87, 680–686 (1977).
   PubMed Web of Science ®Google Scholar
• Feldman M , SchillerLR, WalshJH, FordtranJS, RichardsonCT. Positive intravenous secretin test in patients with achlorhydria-related hypergastrinemia. Gastroenterology93, 59–62 (1987).
   PubMed Web of Science ®Google Scholar
• Dyck WP . Pancreatic hypersecretion in the Zollinger-Ellison syndrome. Case report. Gastroenterology60(1), 90–95 (1971).
   PubMed Web of Science ®Google Scholar
• Dreiling DA , GreensteinA. Pancreatic function in patients with Zollinger-Ellison syndrome. Observations concerning acid-bicarbonate secretion ratios. Am. J. Gastroenterol.58(1), 66–72 (1972).
   PubMed Web of Science ®Google Scholar
• Schaffalitzky de Muckadell OB , FahrenkrugJ. Radioimmunoassay of secretin in plasma. Scand. J. Clin. Lab. Invest.37(2), 155–162 (1977).
   PubMed Web of Science ®Google Scholar
• Gedde-Dahl D . Radioimmunoassay of gastrin. Fasting serum levels in humans with normal and high gastric acid secreation. Scand. J. Gastroenterol.9(1), 41–47 (1974).
   PubMed Web of Science ®Google Scholar
• Wesdorp RI , FischerJE. Plasma-gastrin and acid secretion in patients with peptic ulceration. Lancet2(7885), 857–860 (1974).
   PubMed Web of Science ®Google Scholar
• Steen J , HerningM, ChristiansenPM, RehfeldJF. Relationship between basal serum gastrin concentrations and gastric acid secretion in peptic ulcer disease. Scand. J. Gastroenterol.15(8), 949–952 (1980).
   PubMed Web of Science ®Google Scholar
• Trudeau WL , McGuiganJE. Relations between serum gastrin levels and rates of gastric hydrochloric acid secretion. N. Engl. J. Med.284(8), 408–412 (1971).
   PubMed Web of Science ®Google Scholar
• Minalyan A , BenhammouJN, ArtashesyanA, LewisMS, PisegnaJR. Autoimmune atrophic gastritis: current perspectives. Clin. Exp. Gastroenterol.10, 19–27 (2017).
   PubMed Web of Science ®Google Scholar
• Dixon MF , GentaRM, YardleyJHCP. Classification and grading of gastritis. The upgraded Sydney System. International workshop on the histopathology of gastritis, Houston 1994. Am. J. Surg. Pathol.20(10), 1161–1181 (1996).
   PubMed Web of Science ®Google Scholar
• Dai YC , TangZP, ZhangYL. How to assess the severity of atrophic gastritis. World J. Gastroenterol.17(13), 1690–1693 (2011).
   PubMed Web of Science ®Google Scholar
• Oh DS , WangHS, OhningGV, PisegnaJR. Validation of a new endoscopic technique to assess acid output in Zollinger-Ellison syndrome. Clin. Gastroenterol. Hepatol.4(12), 1467–1473 (2006).
   PubMed Web of Science ®Google Scholar
• Corleto VD , GoebelSU, PanzutoFet al. Co-existence of hyperparathyroidism, hypergastrinemia, and multiple gastric carcinoids is not always due to incomplete expression of the MEN-1 syndrome. Dig. Liver Dis.35(8), 585–589 (2003).
   PubMedGoogle Scholar
• Corleto VD , MinisolaS, MorettiAet al. Prevalence and causes of hypergastrinemia in primary hyperparathyroidism: a prospective study. J. Clin. Endocrinol. Metab.84(12), 4554–4558 (1999).
   PubMed Web of Science ®Google Scholar
• Massironi S , CavalcoliF, RossiREet al. Chronic autoimmune atrophic gastritis associated with primary hyperparathyroidism: a transversal prospective study. Eur. J. Endocrinol.168(5), 755–761 (2013).
   PubMed Web of Science ®Google Scholar
• Lamers CB , RotterJI, JansenJB. Gastrin cell function in familial multiple endocrine neoplasia type I. Gut29, 1358–1363 (1988).
   PubMed Web of Science ®Google Scholar
• Skogseid B , ObergK, BensonLet al. A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. J. Clin. Endocrinol. Metab.64(6), 1233–1240 (1987).
   PubMed Web of Science ®Google Scholar
• Weber HC , VenzonDJ, JensenRT, MetzDC. Studies on the interrelation between Zollinger-Ellison syndrome, Helicobacter pylori and proton pump inhibitor therapy. Gastroenterology112, 84–91 (1997).
   PubMed Web of Science ®Google Scholar
• Naswa N , SharmaP, SoundararajanRet al. Diagnostic performance of somatostatin receptor PET/CT using (68)Ga-DOTANOC in gastrinoma patients with negative or equivocal CT findings. Abdom. Imaging38(3), 552–560 (2013).
   PubMedGoogle Scholar
• Krenning EP , KwekkeboomDJ, BakkerWHet al. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med.20, 716–731 (1993).
   PubMedGoogle Scholar
• Sato M , KiilF, NishitaniAet al. Large and asymptomatic pancreatic islet cell tumor in a patient with multiple endocrine neoplasia type 1. Endocrine13(3), 263–266 (2000).
   PubMed Web of Science ®Google Scholar
• Hayashi M , FloydJCJr, PekS, FajansSS. Insulin, proinsulin, glucagon and gastrin in pancreatic tumors and in plasma of patients with organic hyperinsulinism. J. Clin. Endocrinol. Metab.44(4), 681–694 (1977).
   PubMed Web of Science ®Google Scholar
• Liu TH , TsengHC, ZhuYet al. Insulinoma. An immunocytochemical and morphologic analysis of 95 cases. Cancer56(6), 1420–1429 (1985).
   PubMed Web of Science ®Google Scholar
• Yamaguchi K , EnjojiM. Endocrine neoplasms of the pancreas: a clinicopathologic study of 24 cases and immunohistochemical remarks. Surg. Today22(4), 305–312 (1992).
   PubMed Web of Science ®Google Scholar
• Gurevich L , KazantsevaI, IsakovVAet al. The analysis of immunophenotype of gastrin-producing tumors of the pancreas and gastrointestinal tract. Cancer98(9), 1967–1976 (2003).
   PubMed Web of Science ®Google Scholar
• Heitz PU , KasperM, PolakJM, KloppelG. Pancreatic endocrine tumors. Immunohistochemial analysis of 125 tumors. Hum. Pathol.13, 263–271 (1982).
   PubMed Web of Science ®Google Scholar
• Mukai K , GrottingJC, GreiderMH, RosaiJ. Retrospective study of 77 pancreatic endocrine tumors using the immunoperoxidase method. Am. J. Surg. Pathol.6, 387–399 (1982).
   PubMed Web of Science ®Google Scholar
• Tomita T . Immunocytochemical staining for islet amyloid polypeptide in pancreatic endocrine tumors. Islets3(6), 344–351 (2011).
   PubMed Web of Science ®Google Scholar
• Epelboym I , MazehH. Zollinger-Ellison syndrome: classical considerations and current controversies. Oncologist19(1), 44–50 (2014).
   PubMed Web of Science ®Google Scholar
• Granberg D . Biochemical testing in patients with neuroendocrine tumors. Front. Horm. Res.44, 24–39 (2015).
   PubMed Web of Science ®Google Scholar
• Redeen S , PeterssonF, KechagiasS, MardhE, BorchK. Natural history of chronic gastritis in a population-based cohort. Scand. J. Gastroenterol.45(5), 540–549 (2010).
   PubMed Web of Science ®Google Scholar
• Yao JC , EisnerMP, LearyCet al. Population-based study of islet cell carcinoma. Ann. Surg. Oncol.14(12), 3492–3500 (2007).
   PubMed Web of Science ®Google Scholar
• Kaemmerer D , PeterL, LuppAet al. Molecular imaging with (6)(8)Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours. Eur. J. Nucl. Med. Mol. Imaging38(9), 1659–1668 (2011).
   PubMed Web of Science ®Google Scholar
• Sclafani F , CarnaghiC, Di TommasoLet al. Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors. Tumori97(5), 620–628 (2011).
   PubMed Web of Science ®Google Scholar
• Sollini M , ErbaPA, FraternaliAet al. PET and PET/CT with 68gallium-labeled somatostatin analogues in Non GEP-NETs Tumors. ScientificWorldJournal 2014, 194123 (2014).
   Google Scholar
• Norton JA , AlexanderHR, FrakerDL, VenzonDJ, JensenRT. Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases or survival in patients with Zollinger-Ellison syndrome (ZES)?Ann. Surg.239(5), 617–626 (2004).
   PubMed Web of Science ®Google Scholar
• Norton JA , JensenRT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann. Surg.240(5), 757–773 (2004).
   PubMed Web of Science ®Google Scholar
• Ruszniewski P , AmouyalP, AmouyalGet al. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery117, 629–635 (1995).
   PubMed Web of Science ®Google Scholar
• Goldman JA , BlantonWP, HayDW, WolfeMM. Case report: false-positive secretin stimulation test for gastrinoma associated with the use of proton pump inhibitor therapy. Clin. Gastroenterol. Hepatol.7(5), 600–602 (2009).
   PubMed Web of Science ®Google Scholar
• Grant CS . Insulinoma. Best Pract. Res. Clin. Gastroenterol.19(5), 783–798 (2005).
   PubMed Web of Science ®Google Scholar
• Jensen RT . Overview of chronic diarrhea caused by functional neuroendocrine neoplasms. Semin. Gastrointest. Dis.10(4), 156–172 (1999).
   PubMedGoogle Scholar
• Zimmer V , SchillingMK, BueckerA, LammertF, RaedleJ. Chronic diarrhea responding to proton pump inhibitors: a clinical sign of Zollinger-Ellison syndrome. Am. J. Med.122(11), e9–e10 (2009).
   PubMed Web of Science ®Google Scholar
• Mignon M , RuszniewskiP, HaffarSet al. Current approach to the management of tumoral process in patients with gastrinoma. World J. Surg.10, 703–710 (1986).
   PubMed Web of Science ®Google Scholar
• Law EH , BadowskiM, HungYTet al. Association between proton pump inhibitors and microscopic colitis. Ann. Pharmacother.51(3), 253–263 (2017).
   PubMed Web of Science ®Google Scholar
• Masclee GM , ColomaPM, KuipersEJ, SturkenboomMC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am. J. Gastroenterol.110(5), 749–759 (2015).
   PubMed Web of Science ®Google Scholar
• Vaezi MF , YangYX, HowdenCW. Complications of proton pump inhibitor therapy. Gastroenterology153(1), 35–48 (2017).
   PubMed Web of Science ®Google Scholar
• Sadowski SM , MilloC, Cottle-DelisleCet al. Results of (68)gallium-DOTATATE PET/CT scanning in patients with multiple endocrine neoplasia type 1. J. Am. Coll. Surg.221(2), 509–517 (2015).
   PubMed Web of Science ®Google Scholar
• Gibril F , ChenY-J, SchrumpDSet al. Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab.88(3), 1066–1081 (2003).
   PubMed Web of Science ®Google Scholar
• Gibril F , ReynoldsJC, RoyPKet al. Ability of somatostatin receptor scintigraphy to identify patients with localized gastric carcinoids: a prospective study. J. Nucl. Med.41(10), 1646–1656 (2000).
   PubMed Web of Science ®Google Scholar
• Lastoria S , MarcielloF, FaggianoAet al. Role of Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1). Endocrine52(3), 488–494 (2016).
   PubMed Web of Science ®Google Scholar
• Rusak E , ChobotA, KrzywickaA, WenzlauJ. Anti-parietal cell antibodies – diagnostic significance. Adv. Med. Sci.61(2), 175–179 (2016).
   PubMed Web of Science ®Google Scholar
• Dinis-Ribeiro M , KuipersEJ. Identification of gastric atrophic changes: from histopathology to endoscopy. Endoscopy47(6), 533–537 (2015).
   PubMed Web of Science ®Google Scholar
• Dursun M , YilmazS, YukselenVet al. Evaluation of optimal gastric mucosal biopsy site and number for identification of Helicobacter pylori, gastric atrophy and intestinal metaplasia. Hepatogastroenterology51(60), 1732–1735 (2004).
   PubMedGoogle Scholar
• Lahner E , NormanGL, SeveriCet al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am. J. Gastroenterol.104(8), 2071–2079 (2009).
   PubMed Web of Science ®Google Scholar
• Chen TK , WuCH, LeeCL, LaiYC, YangSS. Endoscopic ultrasonography in the differential diagnosis of giant gastric folds. J. Formos. Med. Assoc.98(4), 261–264 (1999).
   PubMed Web of Science ®Google Scholar
• Cooper BT . Menetrier’s disease. Dig. Dis.5(1), 33–40 (1987).
   PubMedGoogle Scholar
• Lambrecht NW . Menetrier’s disease of the stomach: a clinical challenge. Curr. Gastroenterol. Rep.13(6), 513–517 (2011).
   PubMedGoogle Scholar
• Gibril F , LindemanRJ, Abou-SaifAet al. Retained gastric antrum syndrome. A forgotten, treatable cause of refractory peptic ulcer disease. Dig. Dis. Sci.46(3), 610–617 (2001).
   PubMed Web of Science ®Google Scholar
• Frucht H , HowardJM, SlaffJIet al. Secretin and calcium provocative tests in the Zollinger-Ellison syndrome: a prospective study. Ann. Intern. Med.111, 713–722 (1989).
   PubMed Web of Science ®Google Scholar